Literature DB >> 33007258

A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.

Han Chen1, Han Liang2.   

Abstract

Although enhancers play critical roles in cancer, quantifying enhancer activities in clinical samples remains challenging, especially for super-enhancers. Enhancer activities can be inferred from enhancer RNA (eRNA) signals, which requires enhancer transcription loci definition. Only a small proportion of human eRNA loci has been precisely identified, limiting investigations of enhancer-mediated oncogenic mechanisms. Here, we characterize super-enhancer regions using aggregated RNA sequencing (RNA-seq) data from large cohorts. Super-enhancers usually contain discrete loci featuring sharp eRNA expression peaks. We identify >300,000 eRNA loci in ∼377 Mb super-enhancer regions that are regulated by evolutionarily conserved, well-positioned nucleosomes and are frequently dysregulated in cancer. The eRNAs provide explanatory power for cancer phenotypes beyond that provided by mRNA expression through resolving intratumoral heterogeneity with enhancer cell-type specificity. Our study provides a high-resolution map of eRNA loci through which super-enhancer activities can be quantified by RNA-seq and a user-friendly data portal, enabling a broad range of biomedical investigations.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GTEx; The Cancer Genome Atlas; immunotherapy; nucleosome binding; super enhancer

Mesh:

Substances:

Year:  2020        PMID: 33007258      PMCID: PMC7658066          DOI: 10.1016/j.ccell.2020.08.020

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  95 in total

1.  Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.

Authors:  Stephen C J Parker; Michael L Stitzel; D Leland Taylor; Jose Miguel Orozco; Michael R Erdos; Jennifer A Akiyama; Kelly Lammerts van Bueren; Peter S Chines; Narisu Narisu; Brian L Black; Axel Visel; Len A Pennacchio; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

2.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

3.  eRNAs are required for p53-dependent enhancer activity and gene transcription.

Authors:  Carlos A Melo; Jarno Drost; Patrick J Wijchers; Harmen van de Werken; Elzo de Wit; Joachim A F Oude Vrielink; Ran Elkon; Sónia A Melo; Nicolas Léveillé; Raghu Kalluri; Wouter de Laat; Reuven Agami
Journal:  Mol Cell       Date:  2012-12-27       Impact factor: 17.970

4.  Nucleosome positioning changes during human embryonic stem cell differentiation.

Authors:  Wenjuan Zhang; Yaping Li; Michael Kulik; Rochelle L Tiedemann; Keith D Robertson; Stephen Dalton; Shaying Zhao
Journal:  Epigenetics       Date:  2016-04-18       Impact factor: 4.528

5.  High-resolution view of the yeast meiotic program revealed by ribosome profiling.

Authors:  Gloria A Brar; Moran Yassour; Nir Friedman; Aviv Regev; Nicholas T Ingolia; Jonathan S Weissman
Journal:  Science       Date:  2011-12-22       Impact factor: 47.728

6.  Widespread Chromatin Accessibility at Repetitive Elements Links Stem Cells with Human Cancer.

Authors:  Nicholas C Gomez; Austin J Hepperla; Raluca Dumitru; Jeremy M Simon; Fang Fang; Ian J Davis
Journal:  Cell Rep       Date:  2016-11-01       Impact factor: 9.423

7.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt.

Authors:  Steffen Durinck; Paul T Spellman; Ewan Birney; Wolfgang Huber
Journal:  Nat Protoc       Date:  2009-07-23       Impact factor: 13.491

8.  Controls of nucleosome positioning in the human genome.

Authors:  Daniel J Gaffney; Graham McVicker; Athma A Pai; Yvonne N Fondufe-Mittendorf; Noah Lewellen; Katelyn Michelini; Jonathan Widom; Yoav Gilad; Jonathan K Pritchard
Journal:  PLoS Genet       Date:  2012-11-15       Impact factor: 5.917

9.  Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks.

Authors:  Flavia Michelini; Sethuramasundaram Pitchiaya; Valerio Vitelli; Sheetal Sharma; Ubaldo Gioia; Fabio Pessina; Matteo Cabrini; Yejun Wang; Ilaria Capozzo; Fabio Iannelli; Valentina Matti; Sofia Francia; G V Shivashankar; Nils G Walter; Fabrizio d'Adda di Fagagna
Journal:  Nat Cell Biol       Date:  2017-11-27       Impact factor: 28.824

10.  DANPOS: dynamic analysis of nucleosome position and occupancy by sequencing.

Authors:  Kaifu Chen; Yuanxin Xi; Xuewen Pan; Zhaoyu Li; Klaus Kaestner; Jessica Tyler; Sharon Dent; Xiangwei He; Wei Li
Journal:  Genome Res       Date:  2012-11-28       Impact factor: 9.043

View more
  21 in total

1.  Master lineage transcription factors anchor trans mega transcriptional complexes at highly accessible enhancer sites to promote long-range chromatin clustering and transcription of distal target genes.

Authors:  Shannon M White; Michael P Snyder; Chunling Yi
Journal:  Nucleic Acids Res       Date:  2021-12-02       Impact factor: 16.971

2.  Population-level variation in enhancer expression identifies disease mechanisms in the human brain.

Authors:  Pengfei Dong; Gabriel E Hoffman; Pasha Apontes; Jaroslav Bendl; Samir Rahman; Michael B Fernando; Biao Zeng; James M Vicari; Wen Zhang; Kiran Girdhar; Kayla G Townsley; Ruth Misir; Kristen J Brennand; Vahram Haroutunian; Georgios Voloudakis; John F Fullard; Panos Roussos
Journal:  Nat Genet       Date:  2022-09-26       Impact factor: 41.307

3.  Analysis of estrogen-regulated enhancer RNAs identifies a functional motif required for enhancer assembly and gene expression.

Authors:  Tim Y Hou; W Lee Kraus
Journal:  Cell Rep       Date:  2022-06-14       Impact factor: 9.995

Review 4.  Harnessing big data to characterize immune-related adverse events.

Authors:  Ying Jing; Jingwen Yang; Douglas B Johnson; Javid J Moslehi; Leng Han
Journal:  Nat Rev Clin Oncol       Date:  2022-01-17       Impact factor: 65.011

Review 5.  Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance.

Authors:  Guo-Hua Li; Qiang Qu; Ting-Ting Qi; Xin-Qi Teng; Hai-Hong Zhu; Jiao-Jiao Wang; Qiong Lu; Jian Qu
Journal:  J Exp Clin Cancer Res       Date:  2021-05-19

6.  Recurrent Superenhancer of the Oncogene POU5F1B in Colorectal Cancers.

Authors:  Han-Chuan Tao; Cheng Wang; Ning Ma; Xun Zhu; Xiao-Jun Zhou
Journal:  Biomed Res Int       Date:  2021-12-11       Impact factor: 3.411

7.  Animal-eRNAdb: a comprehensive animal enhancer RNA database.

Authors:  Weiwei Jin; Guanghui Jiang; Yanbo Yang; Jianye Yang; Wenqian Yang; Dongyang Wang; Xiaohui Niu; Rong Zhong; Zhao Zhang; Jing Gong
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

Review 8.  Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer.

Authors:  Rui Wang; Qianzi Tang
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

9.  A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer.

Authors:  Linbang Wang; Jingkun Liu; Jiaojiao Tai; Nian Zhou; Tianji Huang; Yuzhou Xue; Zhengxue Quan
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

Review 10.  Molecular Mechanisms of lncRNAs in the Dependent Regulation of Cancer and Their Potential Therapeutic Use.

Authors:  Carlos García-Padilla; Ángel Dueñas; Virginio García-López; Amelia Aránega; Diego Franco; Virginio Garcia-Martínez; Carmen López-Sánchez
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.